Using Sequence Data to Build Stronger Biologics Patent Value

The increasingly crowded and complex biologics space is evolving faster than companies can manage sequence information to secure and protect their valuable IP assets. Missing critical sequence information during biologics R&D can delay progress and result in weaker patent claims and greater legal risks.

Join us for a webinar with IPWatchdog as our panel of industry experts discusses these challenges and ways to use quality sequence data more effectively to build stronger biologics patents. Our panel will include Gene Quinn, IPWatchdog Founder, President & CEO; Anne Marie Clark, Ph.D., Senior Scientist at CAS IP ServicesSM; Ronald C. Kern, Jr., Ph.D., Esq., Partner, BakerHostetler; and Constantine Linnik, Founder and Managing Partner, IP Supra, PLLC.

What you will learn

• Latest trends in the rapidly changing biologics landscape 
• Challenges in retrieving sequence data versus traditional pharma chemical data  
• How sequence search data can help you pinpoint IP value throughout R&D 
• Best practices in using sequence search data to build stronger patent claims 
• Missteps to avoid when searching and using sequence data during R&D